Christopher Potts, J - General Counsel

Christopher Potts is a highly regarded expert in the biotech industry, known for his proficiency in developing and monetizing intellectual property assets as well as advanced therapies. With over a decade of experience as an intellectual property attorney, both in-house and as external counsel, Chris has established and led IP departments at several publicly traded multinational companies. He has successfully negotiated billion-dollar transactions, managed significant litigations including employment and intellectual property issues, and built businesses in the advanced therapy field. Chris's background positions him ideally to drive growth for Persephoni.

Chris commenced his entrepreneurial journey on his family’s farm in Northeast Ohio, raising hogs and sheep for market. He holds a Bachelor of Science degree in Chemical and Biomolecular Engineering from The Ohio State University and a Juris Doctorate from the University of Connecticut School of Law, where he graduated with honors. He was recognized as the recipient of the American Bar Association’s Scholarship and Leadership Award for his leadership of the Connecticut Journal of International Law as Editor-In-Chief and his role in the University’s Intellectual Property Association. Starting his career at major law firms in Boston and Atlanta, Chris later joined Lonza Inc., where he led legal teams supporting various Lonza businesses, including the Cell and Gene Division and Biologics Division.